Works matching IS 01052896 AND DT 2017 AND VI 276 AND IP 1

Results: 15

TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy.

Published in:

Immunological Reviews, 2017, v. 276, n. 1, p. 112, doi. 10.1111/imr.12518

By:

Dougall, William C.;
Kurtulus, Sema;
Smyth, Mark J.;
Anderson, Ana C.

Publication type:

Article

LAG3 ( CD223) as a cancer immunotherapy target.

Published in:

Immunological Reviews, 2017, v. 276, n. 1, p. 80, doi. 10.1111/imr.12519

By:

Andrews, Lawrence P.;
Marciscano, Ariel E.;
Drake, Charles G.;
Vignali, Dario A. A.

Publication type:

Article

Potential targeting of B7-H4 for the treatment of cancer.

Published in:

Immunological Reviews, 2017, v. 276, n. 1, p. 40, doi. 10.1111/imr.12530

By:

Podojil, Joseph R.;
Miller, Stephen D.

Publication type:

Article

Introduction to checkpoint inhibitors and cancer immunotherapy.

Published in:

Immunological Reviews, 2017, v. 276, n. 1, p. 5, doi. 10.1111/imr.12531

By:

Sharpe, Arlene H.

Publication type:

Article

Issue Information.

Published in:: Immunological Reviews, 2017, v. 276, n. 1, p. 1, doi. 10.1111/imr.12487
Publication type:: Article

Tim-3 and its role in regulating anti-tumor immunity.

Published in:

Immunological Reviews, 2017, v. 276, n. 1, p. 97, doi. 10.1111/imr.12520

By:

Das, Madhumita;
Zhu, Chen;
Kuchroo, Vijay K.

Publication type:

Article

The third group of the B7- CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.

Published in:

Immunological Reviews, 2017, v. 276, n. 1, p. 26, doi. 10.1111/imr.12521

By:

Janakiram, Murali;
Shah, Urvi A.;
Liu, Weifeng;
Zhao, Aimin;
Schoenberg, Mark P.;
Zang, Xingxing

Publication type:

Article

TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy.

Published in:

Immunological Reviews, 2017, v. 276, n. 1, p. 165, doi. 10.1111/imr.12522

By:

Akalu, Yemsratch T.;
Rothlin, Carla V.;
Ghosh, Sourav

Publication type:

Article

Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.

Published in:

Immunological Reviews, 2017, v. 276, n. 1, p. 192, doi. 10.1111/imr.12523

By:

Kean, Leslie S.;
Turka, Laurence A.;
Blazar, Bruce R.

Publication type:

Article

New checkpoints in cancer immunotherapy.

Published in:

Immunological Reviews, 2017, v. 276, n. 1, p. 52, doi. 10.1111/imr.12524

By:

Ni, Ling;
Dong, Chen

Publication type:

Article

Immunoregulatory functions of VISTA.

Published in:

Immunological Reviews, 2017, v. 276, n. 1, p. 66, doi. 10.1111/imr.12525

By:

Nowak, Elizabeth C.;
Lines, J. Louise;
Varn, Frederick S.;
Deng, Jie;
Sarde, Aurelien;
Mabaera, Rodwell;
Kuta, Anna;
Le Mercier, Isabelle;
Cheng, Chao;
Noelle, Randolph J.

Publication type:

Article

Viewing Siglecs through the lens of tumor immunology.

Published in:

Immunological Reviews, 2017, v. 276, n. 1, p. 178, doi. 10.1111/imr.12526

By:

Fraschilla, Isabella;
Pillai, Shiv

Publication type:

Article

The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.

Published in:

Immunological Reviews, 2017, v. 276, n. 1, p. 145, doi. 10.1111/imr.12527

By:

Matlung, Hanke L.;
Szilagyi, Katka;
Barclay, Neil A.;
Berg, Timo K.

Publication type:

Article

The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.

Published in:

Immunological Reviews, 2017, v. 276, n. 1, p. 121, doi. 10.1111/imr.12528

By:

Allard, Bertrand;
Longhi, Maria Serena;
Robson, Simon C.;
Stagg, John

Publication type:

Article

Co-inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma.

Published in:

Immunological Reviews, 2017, v. 276, n. 1, p. 9, doi. 10.1111/imr.12529

By:

Lucca, Liliana E.;
Hafler, David A.

Publication type:

Article